RecruitingNot ApplicableNCT07495059

Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

Sponsor

University of California, Los Angeles

Enrollment

80 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

HIV (Human Immunodeficiency Virus)Stigma Continuum of Care

Summary

Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.

Eligibility

Sex: MALEMin Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called TransAction for people with continuum of care, hiv (human immunodeficiency virus), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 16 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTransAction

Immediately following the baseline, participants in the intervention condition will be invited to participate in the individual and group sessions, with topics around reducing HIV risk behaviors, regular HIV/CD4/viral load testing, ART/PrEP uptake and adherence, and family/social support, all to be completed within three months. All participants, including those in both intervention and control conditions, will be invited to two social events to disseminate health information, HIV prevention messages, and foster social support in a festive, party-style atmosphere.